Literature DB >> 9565776

In vitro antioxidant properties of calcium dobesilate.

J Brunet1, J C Farine, R P Garay, P Hannaert.   

Abstract

Calcium dobesilate, a vascular protective agent, was tested in vitro for its scavenging action against oxygen free radicals. Calcium dobesilate was as potent as rutin to scavenge hydroxyl radicals (IC50 = 1.1 vs 0.7 microM, respectively). It was also able to scavenge superoxide radicals, but with 23 times less potency than rutin (IC50 = 682 vs 30 microM, respectively). Calcium dobesilate significantly reduced platelet activating factor (PAF)-induced chemiluminescence in human PMN cells and lipid peroxidation by oxygen free radicals in human erythrocyte membranes, although these actions required calcium dobesilate concentrations > or = 50 microM. Finally, in cultured bovine aortic endothelial cells, magnesium dobesilate reduced the increase in cytosolic free calcium induced by hydrogen peroxide and inhibited phenazine methosulfate-induced cell potassium loss. In conclusion, calcium dobesilate was effective in scavenging hydroxyl radicals in vitro, at therapeutically relevant concentrations. Conversely, higher concentrations of the compound were required to scavenge superoxide radicals or to protect the cells against the deleterious effects of intracellular reactive oxygen species. Further studies in vivo are required to determine if these antioxidant properties of calcium dobesilate can play a role in its vascular protective mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9565776     DOI: 10.1111/j.1472-8206.1998.tb00943.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  10 in total

1.  Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two cases.

Authors:  Pedro Cuevas; Luis Outeiriño; Carlos Azanza; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-09-03

2.  Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.

Authors:  Maria L Ribeiro; Andras I Seres; Angela M Carneiro; Michael Stur; Alain Zourdani; Patricia Caillon; José G Cunha-Vaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

3.  Calcium dobesilate potentiates endothelium-derived hyperpolarizing factor-mediated relaxation of human penile resistance arteries.

Authors:  Javier Angulo; Pedro Cuevas; Argentina Fernández; Sonia Gabancho; Sebastián Videla; Iñigo Sáenz de Tejada
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

4.  Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes.

Authors:  Ermelindo C Leal; João Martins; Paula Voabil; Joana Liberal; Carlo Chiavaroli; Jacques Bauer; José Cunha-Vaz; António F Ambrósio
Journal:  Diabetes       Date:  2010-07-13       Impact factor: 9.461

5.  Can calcium dobesilate be used safely for peripheral microvasculopathies that require neoangiogenesis?

Authors:  Sinan Demirtas; Ahmet Caliskan; Orkut Guclu; Suleyman Yazici; Oguz Karahan; Celal Yavuz; Binali Mavitas
Journal:  Med Sci Monit Basic Res       Date:  2013-09-27

Review 6.  Non-traditional systemic treatments for diabetic retinopathy: an evidence-based review.

Authors:  Rafael Simó; Stefania Ballarini; José Cunha-Vaz; Linong Ji; Hermann Haller; Paul Zimmet; Tien Y Wong
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 7.  Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate-Free Radical Scavenger and Growth Factor Inhibition.

Authors:  Hermann Haller; Linong Ji; Klaus Stahl; Anna Bertram; Jan Menne
Journal:  Biomed Res Int       Date:  2017-09-26       Impact factor: 3.411

8.  Calcium Dobesilate Restores Autophagy by Inhibiting the VEGF/PI3K/AKT/mTOR Signaling Pathway.

Authors:  Yue Wang; Yun-Hong Lu; Chao Tang; Mei Xue; Xiao-Yu Li; Yun-Peng Chang; Ying Cheng; Ting Li; Xiao-Chen Yu; Bei Sun; Chun-Jun Li; Li-Ming Chen
Journal:  Front Pharmacol       Date:  2019-08-09       Impact factor: 5.810

9.  Calcium dobesilate alleviates renal dysfunction and inflammation by targeting nuclear factor kappa B (NF-κB) signaling in sepsis-associated acute kidney injury.

Authors:  Zhijuan Xie; Lanji Wei; Jianying Chen; Zhong Chen
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

Review 10.  Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.

Authors:  Hervé Allain; Albert A Ramelet; Elisabeth Polard; Danièle Bentué-Ferrer
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.